Has Yelena Rosenberg, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,941 in general payments to Yelena Rosenberg, MD across 75 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Yelena Rosenberg, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Yelena Rosenberg, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Yelena Rosenberg, MD

Nephrology · Mineola, NYNPI 1598763187

Payments from drug & device makers

$2,941in general payments, 2019–2025

Across 75 payments — averaging $39.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$825
Amgen$667
Chiesi USA, Inc.$260
OPKO Pharmaceuticals, LLC$203
Otsuka America Pharmaceutical, Inc.$168
Esperion Therapeutics, Inc.$125
plus $693 from 13 others

What the payments were for

Food & beverage$2,86497%
Education$773%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca(2 entities)	13	$825
Amgen(2 entities)	13	$667
Chiesi USA, Inc.	2	$260
OPKO Pharmaceuticals, LLC	12	$203
Otsuka America Pharmaceutical, Inc.	8	$168
Esperion Therapeutics, Inc.	1	$125
Ardelyx, Inc.	1	$122
Novartis	5	$107
Fresenius USA Marketing, Inc.	4	$89
Akebia Therapeutics Inc	3	$61
Mallinckrodt Hospital Products Inc.	2	$57
Smith+Nephew	1	$43
Fresenius USA Manufacturing, Inc.	2	$41
Vifor Pharma, Inc.	2	$41
Bayer	2	$39
GSK	1	$28
Renalytix AI, Inc.	1	$23
Mallinckrodt Enterprises LLC	1	$21
Aurinia Pharma U.S., Inc.	1	$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,941 in reported general payments places this provider in the 70th percentile of 935 nephrology providers in New York.

See all nephrology providers in New York →

Medicare billing

Part B allowed, 2024

$387,859

Medicare patients

551

Services billed

4,061

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Sevelamer Carbonate	13	$1,874
Calcium Acetate	12	$1,550
Doxazosin Mesylate	44	$738
Amlodipine Besylate	53	$243
Allopurinol	12	$143
Losartan Potassium	11	$19

Paid to pharmacies, not to this prescriber.

Other nephrology in Mineola

Steven FishbaneMineola$1M
Naveed MasaniMineola$715K
Binny KoshyMineola$170K
Joji TokitaNew York$8.4M
Krzysztof KirylukNew York$6.7M
David BernardNew York$6M
Andrew BombackNew York$3.4M
Pietro CanettaNew York$3.2M
Robert LynnBronx$2M
Jodumutt BhatMaspeth$1.5M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →